Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 5Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 186Carcinoma, Non-Small-Cell Lung 144Multiple Myeloma 120Prostatic Neoplasms 118Leukemia, Myeloid, Acute 77Neoplasms 75Colorectal Neoplasms 75Melanoma 72Neoplasm Metastasis 66Lymphoma 66Squamous Cell Carcinoma of Head and Neck 64Lung Neoplasms 64Pancreatic Neoplasms 54Ovarian Neoplasms 50Sarcoma 46Carcinoma, Renal Cell 45Triple Negative Breast Neoplasms 43Glioblastoma 42Urinary Bladder Neoplasms 41Leukemia, Lymphocytic, Chronic, B-Cell 41Carcinoma, Hepatocellular 41Recurrence 40Head and Neck Neoplasms 38Hematologic Neoplasms 37Lymphoma, Large B-Cell, Diffuse 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Myelodysplastic Syndromes 35Lymphoma, Non-Hodgkin 34Brain Neoplasms 34Lymphoma, Mantle-Cell 31

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Active not recruiting × Prostatic Hyperplasia × Clear all
NCT04879940 2026-05-20

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
17 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡